# Technical Data Sheet
Keywords: Avonex, interferon beta-1a, multiple sclerosis, injection, therapeutic indications

> This page provides detailed information about Avonex, a medication containing interferon beta-1a, used for the treatment of multiple sclerosis. It includes its composition, pharmaceutical form, clinical data, and administration guidelines.

## Details
- [Medication Name](#): Avonex 30 micrograms/0.5 ml solution in a prefilled pen.
- [Composition](#): Contains 30 micrograms (6 million IU) of interferon beta-1a per 0.5 ml solution.
- [Pharmaceutical Form](#): Injectable solution in a prefilled pen; clear and colorless solution.
- [Clinical Data](#): Approved for use in adults with relapsing multiple sclerosis or a single demyelinating event with active inflammation.
- [Dosage and Administration](#): Recommended dose is 30 micrograms (0.5 ml) via intramuscular injection once weekly under medical supervision.